29 September 2021
The kick-off meeting of Inno4Vac, a project that targets faster vaccine development and manufacture, by harnessing the power of big data and AI, was held on September 28-29, 2021.
Over the course of two days, representatives from academia, industry and SME partners spoke about the project's vision and future challenges, highlighting the work ahead, namely for the four subtopics to be pursued:
VAXPRED: Systems-immunology platform for model development
CHIMICHURRI: Controlled Human Infection Models (CHIMs)
MERMAID: State-of-art innovations in human in vitro 3D mucosa models and assays
VAXinS: Biomanufacturing platforms using mathematical modelling
We’d like to thank all 150 participants for the informative and engaging presentations.
We look forward to the exciting times ahead.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101007799. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA - https://www.imi.europa.eu. This communication reflects only the author's view and the Joint Undertaking is not responsible for any use that may be made of the information it contains.